Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for HCAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 0.902M
March 31, 2026 -9.406M
December 31, 2025 1.009M
September 30, 2025 -9.353M
June 30, 2025 -52.22M
March 31, 2025 96.76M
December 31, 2024 -112.75M
September 30, 2024 7.646M
June 30, 2024 -1.783M
March 31, 2024 83.98M
December 31, 2023 29.92M
September 30, 2023 -24.86M
June 30, 2023 -7.415M
March 31, 2023 22.65M
December 31, 2022 6.256M
September 30, 2022 -33.18M
June 30, 2022 -13.75M
Date Value
March 31, 2022 1.656M
December 31, 2021 -76.68M
September 30, 2021 -172.79M
June 30, 2021 72.42M
March 31, 2021 37.38M
December 31, 2020 -21.90M
September 30, 2020 -3.976M
June 30, 2020 -106.83M
March 31, 2020 50.15M
December 31, 2019 -22.07M
September 30, 2019 -157.32M
June 30, 2019 -1.558M
March 31, 2019 -28.66M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018 8.809M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 0.00
SCWorx Corp. -0.0726M
GoodRx Holdings, Inc. -14.41M
Claritev Corp. -38.08M
iSpecimen, Inc. 0.00